BIOA Form 144: proposed Common stock sale notice

BIOA submitted a notice under Section 144 relating to proposed sales of Common stock.

Rhea-AI Filing Summary

BIOA submitted a notice under Section 144 relating to proposed sales of Common stock. The excerpt lists transactions dated 09/26/2024 ("IPO Shares", quantity 2,632) and 06/29/2026 ("Stock Option Exercise", quantity 39,718). The filing lists a broker-dealer Fidelity Brokerage Services LLC and shows values including 1,067,577.56 and a figure 44,452,734.

Insights

Securities Counsel

Notice lists proposed resale transactions and broker-dealer details.

The excerpt documents proposed sales of Common stock with two dated entries: 09/26/2024 (IPO Shares, 2,632) and 06/29/2026 (Stock Option Exercise, 39,718). It names Fidelity Brokerage Services LLC and includes numeric figures such as 1,067,577.56.

Timing and cash‑flow treatment are not specified beyond the listed dates. Subsequent regulatory or settlement disclosures will show whether these proposed sales were executed.

Key Figures

IPO Shares: 2,632 shares Stock Option Exercise shares: 39,718 shares Monetary figure: $1,067,577.56 +2 more

5 metrics

IPO Shares 2,632 shares dated 09/26/2024

Stock Option Exercise shares 39,718 shares dated 06/29/2026

Monetary figure $1,067,577.56 listed in the same row as broker details

Numeric entry 44,452,734 appears in the securities row

Broker‑dealer Fidelity Brokerage Services LLC 900 Salem Street, Smithfield RI

Key Terms

IPO Shares, Stock Option Exercise, Form 144

3 terms

IPO Shares financial

"Common | 09/26/2024 | IPO Shares | Issuer"

Stock Option Exercise financial

"06/29/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions does BIOA's Form 144 notice list?

The notice lists two proposed Common stock transactions: 2,632 IPO Shares dated 09/26/2024 and 39,718 shares from a Stock Option Exercise dated 06/29/2026. The excerpt pairs each quantity with its respective date and category.

Which broker‑dealer is named in the BIOA excerpt?

The excerpt names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI. That broker‑dealer is listed in connection with the Common stock entries on the notice.

Does the excerpt show monetary amounts for the proposed sales?

Yes; the excerpt includes $1,067,577.56 alongside other numeric figures such as 44,452,734. The precise label for each amount is not fully specified in the excerpt.

What exchange is referenced for BIOA's securities in the excerpt?

The excerpt indicates the listing market as NASDAQ in a row associated with the Common stock entry. No ticker price or execution detail is provided in the excerpt.

Are these proposed sales described as completed in the excerpt?

The excerpt shows dates and categories for proposed sales but does not state completion. The entries read as notices (proposed transactions) with listed dates and quantities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001836297
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BioAge Labs, Inc.
SEC File Number	001-42279
Address of Issuer	5885 HOLLIS STREET SUITE 370 EMERYVILLE CALIFORNIA 94608
Phone	510-806-1445
Name of Person for Whose Account the Securities are To Be Sold	Barton Shane
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	42350	1067577.56	44452734	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/26/2024	IPO Shares	Issuer			2632	09/26/2024	Cash
Common	06/29/2026	Stock Option Exercise	Issuer			39718	06/29/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shane Barton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)